Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2025-12-24 @ 3:30 PM
NCT ID:
NCT03836092
Brief Summary:
To determine the values and limitations of ECGI in guiding ablation and risk stratification in patients with persistent atrial fibrillation.
Detailed Description:
The patient population will include symptomatic persistent AF patients (N=50). The total of fifty patients will be studied to determine:
* The values and limitations of ECGI in identifying atrial fibrillation (AF) triggers, AF initiators and AF perpetuators as targets sites for catheter ablations in patients with persistent AF.
* The mechanisms of residual atrial tachycardia/flutter (Res-AT/AFl) after AF substrate ablations by targeting complex fractionated atrial electrograms (CFAE).
* If there is a relationship between primary CFAE sites and driver sites or other distinct patterns from the ECGI mapping system.
* The rate of AF termination to sinus rhythm after ablation at target sites identified by ECGI
Study:
NCT03836092
Study Brief:
Protocol Section:
NCT03836092